Jin David's Form 4 filing
Fortress Biotech, Inc.FBIO · filed Nov 19, 2026
- Accession no.
- 0001930732-26-000009
- Filed
- Nov 19, 2026, 5:54 PM ET
- Trade date
- Nov 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $87.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jin DavidCIK 0001930732 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock, par value $0.001 | PPurchaseAcquired | +15,000 | $1.72F1 | +$25,795.5 | 1,667,761 | Direct | |
| Nov 18, 2026 | Common Stock, par value $0.001 | PPurchaseAcquired | +25,000 | $1.91F1 | +$47,797.5 | 1,692,761 | Direct | |
| Nov 19, 2026 | Common Stock, par value $0.001 | PPurchaseAcquired | +7,605 | $1.87F1 | +$14,220.59 | 1,700,366 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The prices reported in Column 4 are weighted average prices. The shares were purchased in multiple transactions in prices ranging from $1.71 to $1.72 on November 17, 2026, $1.8999 to $1.96 on November 18, 2026, and $1.865 to $1.87 on November 19, 2026, in each case inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this note.
Referenced by the price of 3 transactions in Table I.